Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) FCF Margin (2023 - 2026)

Cannabis Bioscience International Holdings' FCF Margin history spans 4 years, with the latest figure at 130.27% for Q1 2026.

  • On a quarterly basis, FCF Margin rose 42436.0% to 130.27% in Q1 2026 year-over-year; TTM through Feb 2026 was 216.87%, a 11227.0% decrease, with the full-year FY2025 number at 108.78%, up 8387.0% from a year prior.
  • FCF Margin hit 130.27% in Q1 2026 for Cannabis Bioscience International Holdings, down from 10.31% in the prior quarter.
  • Over the last five years, FCF Margin for CBIH hit a ceiling of 10.31% in Q4 2025 and a floor of 554.63% in Q1 2025.
  • Historically, FCF Margin has averaged 242.49% across 4 years, with a median of 229.94% in 2024.
  • Biggest five-year swings in FCF Margin: tumbled -52970bps in 2025 and later surged 42436bps in 2026.
  • Tracing CBIH's FCF Margin over 4 years: stood at 347.07% in 2023, then surged by 72bps to 97.09% in 2024, then skyrocketed by 89bps to 10.31% in 2025, then plummeted by -1163bps to 130.27% in 2026.
  • Business Quant data shows FCF Margin for CBIH at 130.27% in Q1 2026, 10.31% in Q4 2025, and 428.56% in Q3 2025.